Melissa Fassbender, of OutSourcing-Pharma, published an article about a SubjectWell survey on Clinical Trial Awareness and Attitudes. For those surveyed: 50% are not aware of clinical trials and 57% could not recall any advertising for clinical trials. The lack of...
Dan Stanton of Outsourcing-Pharma recently published an article on the topic of Clinical Research Associates (CRAs) who have been able to demand higher and higher salaries and bonuses lately. Retaining quality talent has been problematic for companies, and they are...
According to Dan Stanton of Outsourcing-Pharma, CROs who focus on the patient will have the competitive advantage. At the Partnerships in Clinical Trials (PCT) conference in Hamburg, Germany, representatives from AstraZeneca, EMD and Bayer discuss how having a...
In a recent article on Outsourcing Pharma, Dan Stanton discusses the new EU clinical trial regulation and it’s intention to simplify the approval process in hopes of making the EU more accessible and desirable for clinical research. The new regulation will take action...
The 21st Century Cares Act was passed with an overwhelming majority on July 10th, 2015. This bill would increase the funding for both the NIH and FDA and instate a new framework for evaluating patience’s experience with drugs risks and benefits. Not only will the bill...
A recent study by Frost & Sullivan shows that the clinical research market for contract research organizations (CROs) in Latin America are projected to grow at a rate of 7.1% for the next four years, as it predicts that the larger CROs will take the greatest...